Erasca (ERAS) Enterprise Value (2020 - 2026)

Erasca (ERAS) reported Enterprise Value of -$243.8 million for Q1 2026, up 19.96% on a YoY basis from -$203.2 million in Q1 2025, and up 11.7% quarter-over-quarter from -$276.1 million in Q4 2025.

Erasca (ERAS) Enterprise Value (2020 - 2026) Analysis & Trends

Erasca has reported Enterprise Value for 7 years, with the latest figure at -$243.8 million in Q1 2026.

  • For the quarter ending Q1 2026, Enterprise Value rose 19.96% year-over-year to -$243.8 million; the trailing twelve-month figure through Mar 2026 stood at -$243.8 million (up 19.96% YoY), and the FY2025 full-year result was -$276.1 million, up 7.45% from the prior year.
  • Enterprise Value for Q1 2026 stood at -$243.8 million, up from -$276.1 million in the prior quarter.
  • The five-year high for Enterprise Value was -$243.8 million in Q1 2026, with the low at -$435.6 million in Q4 2022.
  • Historically, Enterprise Value has averaged -$330.9 million across 5 years, with a median of -$312.3 million in 2023.
  • Annual changes were most pronounced in 2022 — Enterprise Value sank 130.92% — and 2023, when it advanced 28.3%.
  • Erasca's Enterprise Value stood at -$435.6 million in 2022, then grew by 28.3% to -$312.3 million in 2023, then advanced by 4.5% to -$298.3 million in 2024, then grew by 7.45% to -$276.1 million in 2025, then climbed by 11.7% to -$243.8 million in 2026.
  • The last three Enterprise Value figures came in at -$243.8 million (Q1 2026), -$276.1 million (Q4 2025), and -$288.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Enterprise Value (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -32.30 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -4.14 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -286.70 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -18.44 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -2.77 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -7.20 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -7.25 Bn
9 Abivax 91.96 Bn 91.96 Bn - -584.73 Mn
10 Erasca 4.16 Bn 3.92 Bn - -243.79 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -243.79 Mn
Dec 31, 2025 -276.08 Mn
Sep 30, 2025 -288.40 Mn
Jun 30, 2025 -300.66 Mn
Mar 31, 2025 -304.59 Mn
Dec 31, 2024 -298.31 Mn
Sep 30, 2024 -318.91 Mn
Jun 30, 2024 -408.41 Mn
Mar 31, 2024 -393.76 Mn
Dec 31, 2023 -312.35 Mn
Sep 30, 2023 -296.67 Mn
Jun 30, 2023 -317.25 Mn
Mar 31, 2023 -389.74 Mn
Dec 31, 2022 -435.62 Mn
Sep 30, 2022 -355.93 Mn
Jun 30, 2022 -292.73 Mn
Mar 31, 2022 -392.53 Mn
Dec 31, 2021 -414.48 Mn
Sep 30, 2021 -486.65 Mn
Jun 30, 2021 -193.67 Mn